SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Expansions of in-house R&D will have no impact on CROs, say Pfizer and Lilly

Despite expanding their in-house R&D facilities, both Pfizer and Eli Lilly say they remain committed to using CROs.

Charles River renews early-stage partnership with AstraZeneca for five years

Contract research organization Charles River Laboratories has extended its initial three-year strategic partnership with AstraZeneca for an additional five years. 

INC Research raises guidance for 2015, stock jumps 10%

Contract research organization INC Research reported 14.2% net service revenue growth in Q2, compared to the same quarter last year, raised future guidance and saw its stock bump up more than 10%.

UPDATE

Parexel to lay off up to 125 transferred GSK employees

Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last year, according to a North Carolina WARN report obtained by Outsourcing-Pharma.com.

Growth in biopharma industry buttressing Quintiles’ quarterly earnings

Consistent Q2 growth for the world’s largest CRO (contract research organization) Quintiles was driven by a spike in the company’s Integrated Healthcare Services (IHS) segment.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...